Skip Navigation

European Heart Journal 2001 22(8):618-621; doi:10.1053/euhj.2000.2492
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Woods, D.R.
Right arrow Articles by Montgomery, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woods, D.R.
Right arrow Articles by Montgomery, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorials

Increased QT dispersion with the D-allele of the ACE polymorphism

D.R. Woods, D. Brull and H. Montgomery

Department of Cardiovascular Genetics, University College, London, U.K.
The Rayne Institute, London, U.K.

References

  1. Campbell RW. ACE inhibitors and arrhythmias. Heart. 1996;76:79–82[Abstract/Free Full Text]
  2. Fletcher RD, Cintron GB, Johnson G, Orndorff J, Carson P, Cohn JN. Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. The V-HeFT II VA Cooperative Studies Group. Circulation. 1993;87:V149–155
  3. Yusuf, S, Sleight, P, Pogue, J, Bosch, J, Davies, R, Dagenais, G, Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators [see comments] [published erratum appears inN Engl J Med, 2000 Mar 9, 342, 748, N Engl J Med, 2000, 342, 145, 53
  4. Domanski MJ, Exner DV, Borkowf CB, Geller NL, Rosenberg Y, Pfeffer MA. Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials. J Am Coll Cardiol. 1999;33:598–604[Abstract/Free Full Text]
  5. Jeron A, Hengstenberg C, Engel S. The D-allele of the ACE polymorphism is related to increased QT dispersion in 609 patients after myocardial infarction. Eur Heart J. 2001;22:663–668[Abstract/Free Full Text]
  6. Danser AH, Schalekamp MA, Bax WA. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation. 1995;92:1387–1388[Abstract/Free Full Text]
  7. Elming H, Holm E, Jun L. The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. Eur Heart J. 1998;9:1391–1400
  8. Ledru F, Blanchard D, Battaglia S. Relation between severity of coronary artery disease, left ventricular function and myocardial infarction, and influence of the ACE I/D gene polymorphism. Am J Cardiol. 1998;82:160–165[CrossRef][ISI][Medline]
  9. Linz W, Wiemer G, Scholkens BA. Beneficial effects of bradykinin on myocardial energy metabolism and infarct size. Am J Cardiol. 1997;80:118A–123A[CrossRef][Medline]
  10. Heusch G, Rose J, Ehring T. Cardioprotection by ACE Inhibitors in Myocardial Ischaemia/Reperfusion. Drugs. 1997;54:31–41
  11. Spargias KS, Lindsay SJ, Hall AS, Cowan JC, Ball SG. Ramipril reduces QT dispersion in patients with acute myocardial infarction and heart failure. Am J Cardiol. 1999;83:969–971[CrossRef][ISI][Medline]
  12. Brown NJ, Blais C, Gandhi SK, Adam A. ACE Insertion/Deletion Genotype Affects Bradykinin Metabolism. J Cardiovasc Pharmacol. 1998;32:373–377[CrossRef][ISI][Medline]
  13. Murphey LJ, Gainer JV, Vaughan DE, Brown NJ. Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin. Circulation. 2000;102:829–832[Abstract/Free Full Text]
  14. Evans AE, Poirier O, Kee F. Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. Q J Med. 1994;87:211–214[ISI][Medline]
  15. Marian AJ, Yu QT, Workman R, Greve G, Robert R. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet. 1993;342:1085–1086[CrossRef][ISI][Medline]
  16. Keavney B, McKenzie C, Parish S. Large-scale test of hypothesised associations between the angiotensin- converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators. Lancet. 2000;355:434–442[ISI][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Woods, D.R.
Right arrow Articles by Montgomery, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woods, D.R.
Right arrow Articles by Montgomery, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?